GE HealthCare Technologies Inc. Share Price Deutsche Boerse AG

Equities

L0T

US36266G1076

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate 04:54:06 29/05/2024 pm IST 5-day change 1st Jan Change
72.34 EUR -1.18% Intraday chart for GE HealthCare Technologies Inc. -3.85% +3.51%

Financials

Sales 2024 * 2.02TCr 1.86TCr 1,68100Cr Sales 2025 * 2.12TCr 1.95TCr 1,76400Cr Capitalization 3.59TCr 3.32TCr 2,99600Cr
Net income 2024 * 185.7Cr 171.34Cr 15TCr Net income 2025 * 212Cr 195.61Cr 18TCr EV / Sales 2024 * 2.04 x
Net Debt 2024 * 513.56Cr 473.86Cr 43TCr Net Debt 2025 * 310.78Cr 286.75Cr 26TCr EV / Sales 2025 * 1.85 x
P/E ratio 2024 *
19.4 x
P/E ratio 2025 *
17.1 x
Employees 51,000
Yield 2024 *
0.1%
Yield 2025 *
0.24%
Free-Float 93.07%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.18%
1 week-3.85%
Current month+0.39%
1 month-11.73%
3 months-12.80%
6 months+16.98%
Current year+3.51%
More quotes
1 week
71.94
Extreme 71.94
75.20
1 month
71.66
Extreme 71.66
83.13
Current year
65.00
Extreme 65
86.50
1 year
58.50
Extreme 58.5
86.50
3 years
53.00
Extreme 53
86.50
5 years
53.00
Extreme 53
86.50
10 years
53.00
Extreme 53
86.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 14/22/14
Director of Finance/CFO 51 01/23/01
Chief Tech/Sci/R&D Officer - 01/22/01
Members of the board TitleAgeSince
Director/Board Member 65 14/22/14
Chief Executive Officer 59 14/22/14
Chairman 60 03/23/03
More insiders
Date Price Change Volume
29/24/29 71.94 -1.72% 57
28/24/28 73.2 +1.15% 402
27/24/27 72.37 -1.07% 125
24/24/24 73.15 -0.58% 116
23/24/23 73.58 -1.66% 84

Delayed Quote Deutsche Boerse AG, May 29, 2024 at 03:04 pm IST

More quotes
GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
78.75 USD
Average target price
93.18 USD
Spread / Average Target
+18.32%
Consensus